Insider trade

Precision Biosciences (DTIL): Chief Legal Officer sold ~$28K

Dario Scimeca, Chief Legal Officer at Precision Biosciences, sold ~$28K of Precision Biosciences shares.

~$28K
Approx. value · 2,821 sh @ $9.75
57K
Holds after · shares reported
Traded
Nov 10, 2026
Filed
Nov 12, 2026

What stands out in this filing

  • The sale was 4.7% of the shares this insider held before it; the filing reports 56,782 shares afterwards.
  • 2,821 shares at an average of $9.75 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 25, 2026Insider · 2 peopleInsiders: 2 purchases (~$24K)
  2. Sep 28, 2026Insider · 3 insiders in a week, 5th time since 2019Director purchased ~$6K of DTIL shares in the open market
  3. Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 5.0%
  4. Nov 3, 2026Company filing · Form 8-K · ResultsReported its results
  5. Nov 3, 20265% stakeOctagon Capital Advisors LP reported a passive stake (13G) of 5.7%
  6. Nov 10, 2026 · this disclosureInsiderOfficer sold ~$28K of DTIL shares in the open market

What came next

  1. Nov 16, 20265% stakeLynx1 Capital Management LP reported a passive stake (13G) of 9.9%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Precision Biosciences

For Precision Biosciences, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DTIL page.

Other recent filings by Dario Scimeca, Chief Legal Officer

The full history of Dario Scimeca, Chief Legal Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Precision Biosciences (DTIL) insider traded, and how much?

Dario Scimeca, Chief Legal Officer at Precision Biosciences, sold ~$28K of Precision Biosciences shares. 2,821 shares at $9.75.

When did it happen, and when was it made public?

Traded: Nov 10, 2026. Filed: Nov 12, 2026. That is 2 days between the two dates.

What stands out in this filing?

The sale was 4.7% of the shares this insider held before it; the filing reports 56,782 shares afterwards. 2,821 shares at an average of $9.75 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Precision Biosciences recently?

For Precision Biosciences, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the DTIL page.

Does this mean DTIL stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Precision Biosciences

Everything OQRO holds on this company is on its DTIL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data